Dr. Lindsey Adair MacFarlane, MD

Dr. MacFarlane practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. MacFarlane's NPI, 1366736183, was assigned on June 9, 2011. Dr. MacFarlane graduated from Albany Medical College of Union University in 2011. Dr. MacFarlane holds New Hampshire license 25619.

Dr. MacFarlane's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Dr. MacFarlane's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. MacFarlane is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. MacFarlane to 2 more hospitals, 3 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. MacFarlane practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. MacFarlane's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. MacFarlane's licenses on file in 2 states: New Hampshire and Massachusetts.

CMS data shows 74 Medicare services from Dr. MacFarlane across 2 procedure codes in 2024, all of them office visits, for 52 Medicare patients. Medicare paid $4,603 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Dr. MacFarlane in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have arthritis, and 63% have high blood pressure. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. MacFarlane's median patient age at 61, with 70% women.

In 2024, Dr. MacFarlane wrote 334 Medicare Part D claims for 53 patients. 84% of them were for generic drugs. CMS names the drug for 245 of them, across 10 drugs with 11 or more claims each, at $304,098 in total drug cost. In 2023, CMS named 232 claims across 7 drugs.

Dr. MacFarlane accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. MacFarlane as offering telehealth.

Dmand AI links 33 papers to Dr. MacFarlane, published from 2014 to 2024. 2023 was the busiest year, with 9. The most frequent topics are Osteoarthritis, Knee, Magnetic Resonance Imaging and Knee Joint. Dr. MacFarlane has published most often in Arthritis Care Res (Hoboken). Dr. MacFarlane's most frequent co-authors are Ali Guermazi, MD, Bruce A. Levy, MD and Kurt Spindler, MD.

CMS Open Payments shows 19 general payments to Dr. MacFarlane from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 87% of the total. Flexion Therapeutics, Inc. paid the most, $5,050.

Dr. MacFarlane graduated from Albany Medical College of Union University in 2011.